Cathie Wood's position in Veracyte is currently worth $139 Million. That's 1.32% of their equity portfolio (21st largest holding). The investor owns 5.62% of the outstanding Veracyte stock. The first Veracyte trade was made in Q4 2016. Since then Cathie Wood bought shares eighteen more times and sold shares on twelve occasions. The stake costed the investor $110 Million, netting the investor a gain of 26% so far.